+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bio-imaging Market - Global Forecast 2026-2032- Product Image
Bio-imaging Market - Global Forecast 2026-2032- Product Image
Sale

Bio-imaging Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083269
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bio-imaging Market is projected to reach USD 8.13 Billion in 2026. It is expected to continue growing at a CAGR of 10.55%, reaching USD 14.90 Billion by 2032.

The bio-imaging market is expanding as biomedical research, precision diagnostics, drug discovery, and image-guided care converge around higher-resolution visualization and quantitative image analytics. Demand is supported by the growing global burden of chronic disease; the International Agency for Research on Cancer reported about 20 million new cancer cases in 2022 and projects the total could rise to 35 million by 2050, reinforcing the need for earlier detection, treatment monitoring, and longitudinal imaging.

Across microscopy, MRI, CT, PET, SPECT, ultrasound, optical imaging, digital pathology, and molecular imaging, buyers are prioritizing systems that improve sensitivity, throughput, reproducibility, and workflow efficiency. Transformative Shifts in the Bio-Imaging Landscape

The bio-imaging landscape is shifting from standalone instruments to connected, software-defined imaging ecosystems. Laboratories and hospitals are increasingly seeking interoperable platforms that combine image capture, annotation, storage, analytics, and compliance-ready reporting, especially as multi-omics, spatial biology, and precision oncology require richer imaging context.

Funding and policy are also reshaping adoption. Horizon Europe’s EUR 95.5 billion research program, the U.S. Cancer Moonshot, national precision medicine initiatives, and rising investment in digital pathology are accelerating translational imaging. At the same time, stricter data governance, cybersecurity, and medical device regulations are pushing vendors to build validated, auditable, privacy-preserving, and secure imaging workflows.

Cumulative Impact of Artificial Intelligence on Bio-Imaging

Artificial intelligence is becoming a cumulative force multiplier in bio-imaging by improving image reconstruction, denoising, segmentation, classification, registration, triage, and biomarker quantification. The U.S. FDA’s public list of AI/ML-enabled medical devices surpassed 950 authorizations in 2024, with radiology representing the largest share, demonstrating how algorithmic imaging has moved from experimentation to regulated clinical use.

In research environments, AI supports high-content screening, cell phenotyping, tissue microenvironment analysis, digital pathology review, and automated microscopy quality control. The strongest opportunities will come from explainable AI models, curated and representative datasets, human-in-the-loop validation, and multimodal pipelines that integrate imaging with genomics, proteomics, electronic health records, and laboratory information systems.

Key Regional Insights for Bio-Imaging

Asia-Pacific is gaining momentum through China’s scale in hospital infrastructure, Japan’s advanced imaging installed base, India’s expanding diagnostic access, Australia’s translational research networks, and South Korea’s high R&D intensity; OECD data consistently place South Korea among the world’s highest research-and-development investors as a share of GDP. North America remains a leading commercialization hub because of strong NIH funding, FDA pathways for imaging software, advanced cancer centers, and early adoption of digital pathology, AI radiology, molecular imaging, and cloud-based medical imaging workflows.

Europe benefits from Horizon Europe, the European Health Data Space agenda, and strong academic-industry imaging clusters in Germany, France, the United Kingdom, Italy, and Spain, while EU medical device rules are increasing the importance of clinical evidence and post-market surveillance. Latin America is advancing through Brazil and Mexico’s private diagnostics growth and oncology infrastructure needs, while the Middle East is supported by GCC hospital modernization programs, specialty care expansion, and national digital health strategies. Africa’s opportunity is tied to portable ultrasound, tele-imaging, tuberculosis and infectious disease imaging, maternal health applications, and public-private capacity building to improve access in resource-constrained settings.

Key Group Insights Across Global Bio-Imaging Markets

ASEAN demand is rising as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines invest in diagnostics capacity, biomedical research parks, medical tourism, and digital health infrastructure for large, underserved populations. The GCC is advancing premium imaging, oncology centers, AI-enabled hospital systems, and cloud-connected diagnostics through national transformation strategies, particularly in Saudi Arabia and the United Arab Emirates, where healthcare modernization is a core component of economic diversification.

The European Union provides scale through harmonized research funding, cross-border data policy, and strong biomedical networks, although MDR and IVDR compliance increases evidence expectations for imaging software and diagnostic workflows. BRICS countries broaden opportunity through large patient populations, expanding hospital capacity, scientific research output, and local manufacturing ambitions, while G7 markets remain innovation leaders in premium imaging, reimbursement sophistication, clinical validation, and academic translation. NATO countries add defense-health relevance through trauma imaging, field diagnostics, medical readiness, and resilient medical supply chains that support both civilian and emergency-care bio-imaging applications.

Key Country Insights in Bio-Imaging

The United States leads in biomedical imaging innovation due to large academic medical centers, NIH-backed research, venture funding, advanced radiology and pathology networks, and a mature FDA framework for imaging devices and AI-enabled software. Canada contributes strengths in AI research, population health imaging, and publicly funded care pathways; Mexico benefits from nearshoring, private diagnostics, and cross-border healthcare activity; and Brazil is Latin America’s largest healthcare market, with rising oncology, cardiology, and imaging demand supported by a large hospital base.

In Europe, the United Kingdom, Germany, France, Italy, Spain, and Russia each support demand through hospital modernization, research institutions, and national screening needs, with Germany standing out for engineering, medtech manufacturing, and advanced imaging adoption. The United Kingdom has strengths in genomics-linked imaging research and NHS digital transformation, France supports oncology and nuclear medicine capabilities, Italy and Spain are improving diagnostic capacity across public and private networks, and Russia maintains demand through large tertiary-care systems. In Asia-Pacific, China and India provide scale through expanding healthcare access and chronic disease needs, Japan and South Korea deliver advanced technology adoption and aging-population imaging demand, and Australia contributes high-quality clinical research, cancer imaging networks, population screening programs, and digital health readiness.

Actionable Recommendations for Bio-Imaging Industry Leaders

Industry leaders should prioritize interoperable imaging platforms that connect instruments, laboratory information systems, PACS, cloud repositories, digital pathology systems, and AI analytics. Product roadmaps should emphasize validated software, regulatory documentation, cybersecurity, data provenance, auditability, and compatibility with DICOM, HL7, FHIR, and microscopy metadata standards.

Commercial teams should align offerings with regional evidence requirements, clinical workflows, and buyer economics. In mature markets, differentiation should focus on automation, AI performance, reproducibility, image quality, workflow integration, and total cost of ownership. In emerging markets, portable systems, training, remote support, leasing models, ruggedized equipment, and public-private partnerships can unlock adoption while improving access to biomedical imaging.

Research Methodology

This executive summary is grounded in secondary research from verified public and institutional sources, including regulatory databases, national research funding programs, cancer statistics, peer-reviewed biomedical imaging literature, clinical imaging guidelines, and publicly available policy documents. Sources assessed include agencies such as the FDA, NIH, IARC, WHO, OECD, European Commission, and national health authorities.

The analysis applies a structured market intelligence approach, combining demand-side healthcare indicators, technology adoption signals, regulatory developments, procurement trends, research funding patterns, and regional macroeconomic context. Insights were triangulated across clinical imaging, life science imaging, digital pathology, high-content screening, molecular imaging, preclinical imaging, and AI image analysis to identify durable bio-imaging market drivers without relying on market size, share, or forecast assumptions.

Conclusion

Bio-imaging is becoming a foundational layer of precision medicine, translational research, clinical diagnostics, and pharmaceutical innovation. The market is being shaped by higher disease burden, demand for earlier diagnosis, spatial biology, digital pathology, cloud-connected workflows, and the rapid integration of artificial intelligence into imaging pipelines.

Sustained progress will depend on trust, validation, interoperability, cybersecurity, and measurable workflow value. Organizations that combine high-quality imaging hardware with compliant software, AI-ready data infrastructure, robust clinical evidence, and region-specific commercialization strategies will be best positioned to lead the next phase of the global bio-imaging market.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bio-imaging Market, by Product
7.1. Introduction
7.2. Imaging Systems
7.3. Instruments
7.3.1. CT Scanners
7.3.2. MRI Machines
7.3.3. Ultrasound Devices
7.4. Reagents
7.5. Software
7.5.1. Data Management Software
7.5.2. Image Analysis Software
8. Bio-imaging Market, by Technology
8.1. Introduction
8.2. Endoscopy
8.3. Magnetic Resonance Imaging
8.4. Nuclear Imaging
8.5. Surgical Microscopy
8.6. Ultrasound
8.7. X-ray Imaging
9. Bio-imaging Market, by Modality
9.1. Introduction
9.2. 2D Imaging
9.3. 3D Imaging
10. Bio-imaging Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.3. Drug Discovery
10.4. Research
10.5. Therapeutics
11. Bio-imaging Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Diagnostic Imaging Centers
11.4. Hospitals & Clinics
12. Bio-imaging Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Bio-imaging Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Bio-imaging Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. BaySpec, Inc.
16.2. Bracco S.p.A.
16.3. Bruker Corporation
16.4. Canon Medical Systems Corporation
16.5. Digirad Corporation
16.6. Esaote S.p.A
16.7. Fujifilm Holdings Corporation
16.8. GE HealthCare Technologies, Inc.
16.9. Hitachi Medical Corporation
16.10. HT BioImaging Ltd
16.11. iThera Medical GmbH
16.12. Kitware, Inc.
16.13. Koninklijke Philips N.V.
16.14. Lantheus Medical Imaging, Inc.
16.15. M Squared Lasers Ltd.
16.16. MARS Bioimaging Limited
16.17. Medtronic PLC
16.18. MobileODT Ltd by Liger Medical LLC
16.19. Perspectum Ltd.
16.20. Quibim, S.L.
16.21. RadNet, Inc.
16.22. Rivanna Medical, Inc.
16.23. Samsung Medison Co., Ltd.
16.24. Siemens Healthineers AG
17. Key Experts
List of Figures
FIGURE 1. Global Bio-imaging Market, Years Considered for the Study
FIGURE 2. Global Bio-imaging Market, Research Design
FIGURE 3. Global Bio-imaging Market, Research Framework
FIGURE 4. Global Bio-imaging Market, Data Triangulation
FIGURE 5. Global Bio-imaging Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bio-imaging Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Bio-imaging Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bio-imaging Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Bio-imaging Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bio-imaging Market Size, by Modality, 2025 vs 2032 (%)
FIGURE 11. Global Bio-imaging Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bio-imaging Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Bio-imaging Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bio-imaging Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Bio-imaging Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Bio-imaging Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Bio-imaging Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Bio-imaging Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Bio-imaging Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Bio-imaging Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Bio-imaging Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Bio-imaging Market Segmentation & Coverage
TABLE 2. Global Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Imaging Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global CT Scanners Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global CT Scanners Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global CT Scanners Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global MRI Machines Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global MRI Machines Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global MRI Machines Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Ultrasound Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Ultrasound Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Ultrasound Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Data Management Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Data Management Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Data Management Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Image Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Image Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Image Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 32. Global Endoscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Endoscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Endoscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Magnetic Resonance Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Magnetic Resonance Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Magnetic Resonance Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Nuclear Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Nuclear Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Nuclear Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Surgical Microscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Surgical Microscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Surgical Microscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global X-ray Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global X-ray Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global X-ray Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 51. Global 2D Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global 2D Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global 2D Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global 3D Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global 3D Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global 3D Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 58. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Bio-imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Bio-imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. North America Bio-imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. North America Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 91. North America Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 92. North America Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 93. North America Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 94. North America Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 95. North America Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. North America Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Latin America Bio-imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Latin America Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 99. Latin America Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 100. Latin America Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 101. Latin America Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 102. Latin America Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 103. Latin America Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Latin America Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Europe Bio-imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Europe Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 107. Europe Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 108. Europe Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 109. Europe Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. Europe Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 111. Europe Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Europe Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Middle East Bio-imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Middle East Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 115. Middle East Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 116. Middle East Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 117. Middle East Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 118. Middle East Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 119. Middle East Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Middle East Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Africa Bio-imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Africa Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 123. Africa Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 124. Africa Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 125. Africa Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 126. Africa Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 127. Africa Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Africa Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Global Bio-imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. ASEAN Bio-imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. ASEAN Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 132. ASEAN Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 133. ASEAN Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 134. ASEAN Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. ASEAN Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 136. ASEAN Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. ASEAN Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. GCC Bio-imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. GCC Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 140. GCC Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 141. GCC Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 142. GCC Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. GCC Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 144. GCC Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. GCC Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. European Union Bio-imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. European Union Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 148. European Union Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 149. European Union Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 150. European Union Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. European Union Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 152. European Union Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. European Union Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. BRICS Bio-imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. BRICS Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 156. BRICS Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 157. BRICS Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 158. BRICS Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. BRICS Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 160. BRICS Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. BRICS Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. G7 Bio-imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. G7 Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 164. G7 Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 165. G7 Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 166. G7 Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. G7 Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 168. G7 Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. G7 Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. NATO Bio-imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. NATO Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 172. NATO Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 173. NATO Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 174. NATO Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. NATO Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 176. NATO Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. NATO Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Global Bio-imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. United States Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 180. United States Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 181. United States Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 182. United States Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 183. United States Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. United States Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 185. United States Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. United States Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Canada Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 188. Canada Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 189. Canada Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 190. Canada Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 191. Canada Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. Canada Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 193. Canada Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Canada Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Mexico Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 196. Mexico Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 197. Mexico Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 198. Mexico Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 199. Mexico Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 200. Mexico Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 201. Mexico Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Mexico Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Brazil Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 204. Brazil Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 205. Brazil Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 206. Brazil Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 207. Brazil Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Brazil Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 209. Brazil Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Brazil Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. United Kingdom Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 212. United Kingdom Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 213. United Kingdom Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 214. United Kingdom Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 215. United Kingdom Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 216. United Kingdom Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 217. United Kingdom Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. United Kingdom Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Germany Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 220. Germany Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 221. Germany Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 222. Germany Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 223. Germany Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. Germany Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 225. Germany Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Germany Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. France Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 228. France Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 229. France Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 230. France Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 231. France Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. France Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 233. France Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. France Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Russia Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 236. Russia Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 237. Russia Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 238. Russia Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 239. Russia Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 240. Russia Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 241. Russia Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. Russia Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Italy Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 244. Italy Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 245. Italy Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 246. Italy Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 247. Italy Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. Italy Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 249. Italy Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Italy Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. Spain Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 252. Spain Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 253. Spain Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 254. Spain Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 255. Spain Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. Spain Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 257. Spain Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Spain Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. China Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 260. China Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 261. China Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 262. China Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 263. China Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 264. China Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 265. China Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. China Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. India Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 268. India Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 269. India Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 270. India Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 271. India Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 272. India Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 273. India Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. India Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Japan Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 276. Japan Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 277. Japan Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 278. Japan Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 279. Japan Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. Japan Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 281. Japan Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. Japan Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Australia Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 284. Australia Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 285. Australia Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 286. Australia Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 287. Australia Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. Australia Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 289. Australia Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Australia Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. South Korea Bio-imaging Market Size, 2017-2032 (USD Million)
TABLE 292. South Korea Bio-imaging Market Size, by Product, 2017-2032 (USD Million)
TABLE 293. South Korea Bio-imaging Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 294. South Korea Bio-imaging Market Size, by Software, 2017-2032 (USD Million)
TABLE 295. South Korea Bio-imaging Market Size, by Technology, 2017-2032 (USD Million)
TABLE 296. South Korea Bio-imaging Market Size, by Modality, 2017-2032 (USD Million)
TABLE 297. South Korea Bio-imaging Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. South Korea Bio-imaging Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Global Bio-imaging Market Share, by Key Player, 2025
TABLE 300. Global Bio-imaging Market, Key Experts

Companies Mentioned

  • BaySpec, Inc.
  • Bracco S.p.A.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Digirad Corporation
  • Esaote S.p.A
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi Medical Corporation
  • HT BioImaging Ltd
  • iThera Medical GmbH
  • Kitware, Inc.
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • M Squared Lasers Ltd.
  • MARS Bioimaging Limited
  • Medtronic PLC
  • MobileODT Ltd by Liger Medical LLC
  • Perspectum Ltd.
  • Quibim, S.L.
  • RadNet, Inc.
  • Rivanna Medical, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers AG

Table Information

Report AttributeDetails
No. of Pages187
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.13 Billion
Forecasted Market Value ( USD ) by 2032 $ 14.9 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Bio-imaging Technologies - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Bio-imaging Technologies - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 182 Pages
  • Global
From
Bio Imaging Technologies Market Report 2026 - Product Image

Bio Imaging Technologies Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Surgical Imaging Market - Global Forecast 2026-2032 - Product Image

Surgical Imaging Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Medical Imaging Outsourcing Market - Global Forecast 2026-2032 - Product Image

Medical Imaging Outsourcing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Handheld Echocardiography Devices - Global Strategic Business Report - Product Image

Handheld Echocardiography Devices - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From

About the Bioimaging Market

The Bioimaging market is a subset of the biotechnology industry that focuses on the development and use of imaging technologies to visualize biological processes. This includes the use of microscopy, spectroscopy, and other imaging techniques to observe and analyze biological systems. Bioimaging is used to study the structure and function of cells, tissues, and organs, as well as to monitor the effects of drugs and other treatments. It is also used to diagnose and monitor diseases, such as cancer, and to study the effects of environmental factors on living organisms. Bioimaging technologies are used in a variety of industries, including pharmaceuticals, medical diagnostics, and research. Companies in the Bioimaging market include Nikon, Olympus, Carl Zeiss, Bruker, PerkinElmer, Thermo Fisher Scientific, and Hitachi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.